263 related articles for article (PubMed ID: 30870262)
21. Combined use of electroconvulsive therapy and antipsychotics (both clozapine and non-clozapine) in treatment resistant schizophrenia: A comparative meta-analysis.
Ahmed S; Khan AM; Mekala HM; Venigalla H; Ahmed R; Etman A; Esang M; Qureshi M
Heliyon; 2017 Nov; 3(11):e00429. PubMed ID: 29264404
[TBL] [Abstract][Full Text] [Related]
22. Combined use of clozapine and ECT: a review.
Grover S; Hazari N; Kate N
Acta Neuropsychiatr; 2015 Jun; 27(3):131-42. PubMed ID: 25697225
[TBL] [Abstract][Full Text] [Related]
23. Combined electroconvulsive therapy and clozapine in treatment-resistant schizophrenia.
Kales HC; Dequardo JR; Tandon R
Prog Neuropsychopharmacol Biol Psychiatry; 1999 Apr; 23(3):547-56. PubMed ID: 10378236
[TBL] [Abstract][Full Text] [Related]
24. Combined electroconvulsive-clozapine therapy.
Kupchik M; Spivak B; Mester R; Reznik I; Gonen N; Weizman A; Kotler M
Clin Neuropharmacol; 2000; 23(1):14-6. PubMed ID: 10682225
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of combining clozapine with electrical or magnetic brain stimulation in treatment-refractory schizophrenia.
Arumugham SS; Thirthalli J; Andrade C
Expert Rev Clin Pharmacol; 2016 Sep; 9(9):1245-52. PubMed ID: 27322602
[TBL] [Abstract][Full Text] [Related]
26. Combined clozapine and electroconvulsive therapy in clozapine-resistant schizophrenia: clinical and cognitive outcomes.
Biedermann F; Pfaffenberger N; Baumgartner S; Kemmler G; Fleischhacker WW; Hofer A
J ECT; 2011 Dec; 27(4):e61-2. PubMed ID: 22124226
[TBL] [Abstract][Full Text] [Related]
27. Clinical and cost-effectiveness of electroconvulsive therapy for depressive illness, schizophrenia, catatonia and mania: systematic reviews and economic modelling studies.
Greenhalgh J; Knight C; Hind D; Beverley C; Walters S
Health Technol Assess; 2005 Mar; 9(9):1-156, iii-iv. PubMed ID: 15774232
[TBL] [Abstract][Full Text] [Related]
28. Continuation ECT in treatment-resistant schizophrenia: a controlled study.
Chanpattana W; Chakrabhand ML; Sackeim HA; Kitaroonchai W; Kongsakon R; Techakasem P; Buppanharun W; Tuntirungsee Y; Kirdcharoen N
J ECT; 1999 Sep; 15(3):178-92. PubMed ID: 10492856
[TBL] [Abstract][Full Text] [Related]
29. Case Report: Successful Use of the Combination of Electroconvulsive Therapy and Clozapine in Treating Treatment-Resistant Schizophrenia and Catatonia in an Adult with Intellectual Disability.
Desarkar P; Blumberger D; Daskalakis ZJ
J Autism Dev Disord; 2018 Oct; 48(10):3637-3640. PubMed ID: 29696528
[TBL] [Abstract][Full Text] [Related]
30. A prospective multicenter assessor-blinded randomized controlled study to compare the efficacy of short versus long protocols of electroconvulsive therapy as an augmentation strategy to clozapine in patients with ultra-resistant schizophrenia (SURECT study).
Moulier V; Krir MW; Dalmont M; ; Guillin O; Rothärmel M
Trials; 2021 Apr; 22(1):284. PubMed ID: 33858488
[TBL] [Abstract][Full Text] [Related]
31. Long-lasting leukocytosis in patients with schizophrenia treated with clozapine after electroconvulsive therapy : ECT stabilizes white blood cell count.
Sugita K; Mori Y; Kanemoto K; Sugita S
Sci Prog; 2022; 105(3):368504221117067. PubMed ID: 36000301
[TBL] [Abstract][Full Text] [Related]
32. The combined use of electroconvulsive therapy and antipsychotics in patients with schizophrenia.
Braga RJ; Petrides G
J ECT; 2005 Jun; 21(2):75-83. PubMed ID: 15905747
[TBL] [Abstract][Full Text] [Related]
33. The Effects of Electroconvulsive Therapy Augmentation of Antipsychotic Treatment on Cognitive Functions in Patients With Treatment-Resistant Schizophrenia.
Vuksan Ćusa B; Klepac N; Jakšić N; Bradaš Z; Božičević M; Palac N; Šagud M
J ECT; 2018 Mar; 34(1):31-34. PubMed ID: 29053485
[TBL] [Abstract][Full Text] [Related]
34. Lack of ECT effects on clozapine plasma levels in patients with treatment-resistant schizophrenia: Pharmacokinetic evidence from a randomized clinical trial.
Schoretsanitis G; Mendelowitz A; Malur C; Braga RJ; Schooler NR; John M; de Leon J; Kane JM; Petrides G
Schizophr Res; 2020 Apr; 218():309-311. PubMed ID: 32107101
[No Abstract] [Full Text] [Related]
35. Neuroleptic-resistant schizophrenia treated with clozapine and ECT.
Benatov R; Sirota P; Megged S
Convuls Ther; 1996 Jun; 12(2):117-21. PubMed ID: 8744173
[TBL] [Abstract][Full Text] [Related]
36. Which are the best evidence-based therapeutic options for clozapine and ECT resistant schizophrenia? A case-report.
Damiano RF; Avrichir BS; Melzer-Ribeiro DL; Sallet PC; Elkis H
Psychiatry Res; 2021 Nov; 305():114248. PubMed ID: 34739952
[TBL] [Abstract][Full Text] [Related]
37. Electroconvulsive therapy or clozapine for adolescents with treatment-resistant schizophrenia: an explorative analysis on symptom dimensions.
Tuncturk M; Ermis C; Buyuktaskin D; Turan S; Saglam Y; Alarslan S; Guler D; Sut E; Unutmaz G; Guzel AB; Atay Canbek O; Inal N; Karacetin G; Hazell P
Int J Psychiatry Clin Pract; 2023 Sep; 27(3):257-263. PubMed ID: 36576216
[TBL] [Abstract][Full Text] [Related]
38. Short-term effect of combined ECT and neuroleptic therapy in treatment-resistant schizophrenia.
Chanpattana W; Chakrabhand ML; Kongsakon R; Techakasem P; Buppanharun W
J ECT; 1999 Jun; 15(2):129-39. PubMed ID: 10378152
[TBL] [Abstract][Full Text] [Related]
39. Comparative study of effectiveness of augmentation with ECT in clozapine resistant schizophrenia (CRS) and non-clozapine resistant schizophrenia (Non-CRS).
Grover S; Shouan A; Chakrabarti S; Sahoo S; Mehra A
Nord J Psychiatry; 2021 Aug; 75(6):397-405. PubMed ID: 33630681
[TBL] [Abstract][Full Text] [Related]
40. Electroconvulsive therapy for treating schizophrenia: a chart review of patients from two catchment areas.
Kristensen D; Bauer J; Hageman I; Jørgensen MB
Eur Arch Psychiatry Clin Neurosci; 2011 Sep; 261(6):425-32. PubMed ID: 21132505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
